Google just announced a major shakeup of its top AI leadership
The Verge Jay Peters ● Covered by 4 sources
Google's shuffling its AI chiefs. Demis Hassabis moves up to chair of DeepMind and chief scientist at Alphabet, while Koray Kavukcuoglu takes the SVP reins.
Sundar Pichai dropped a leadership reshuffle on Wednesday that quietly says a lot about where Google thinks AI is headed next. Demis Hassabis, the face of DeepMind for years, is stepping into a new role as chair of Google DeepMind and chief scientist at Alphabet. It's a title bump that sounds ceremonial but isn't — chief scientist roles at companies this size tend to mean setting long-term research direction rather than running day-to-day operations.
That operational job now falls to Koray Kavukcuoglu, DeepMind's former CTO, who becomes Google's SVP of DeepMind and will report directly to Pichai. Kavukcuoglu isn't losing his old hat either — he keeps his title as Google's chief AI architect, meaning he's now both the technical glue and the new executive face of the division. Two jobs, one person, which tells you Google wants continuity more than a clean break.
Hassabis isn't disappearing from the labs, either. He'll keep leading Isomorphic Labs, Alphabet's drug-discovery bet that uses AI to hunt for new medicines. That's notable because it signals where Hassabis's personal ambitions sit these days — less on shipping the next chatbot update, more on the biology and health angle he's talked about publicly for years as AI's most meaningful application.
Google didn't frame this as a demotion, and structurally it isn't one. But moving your most recognizable AI leader up and sideways, while installing a hands-on technical operator underneath him, usually means a company is trying to scale research output without losing its top scientist to some board-level distraction. Pichai gets a chief scientist he can point to publicly, and a chief architect who can actually run the machine.
My take
Nobody should be shocked that Hassabis is angling harder toward drug discovery — the guy has said for years that curing disease is the real prize, and Isomorphic Labs is where the ego and the mission finally line up. The bigger tell here is Google giving a chief-scientist title real teeth instead of using it as a retirement gift, which suggests they're worried about keeping frontier research talent from wandering off to found their own startups, a pattern that's already hollowed out plenty of other labs.
Read more about this at: The Verge
